GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 22, 2025 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
5O9Q | Q06135 | Crystal structure of ScGas2 in complex with compound 6 | |
3CA5 | P33183 | Crystal structure of Sambucus nigra agglutinin II (SNA-II)-tetragonal crystal form- complexed to alpha1 methylgalactose | |
3CA3 | P33183 | Crystal structure of Sambucus Nigra Agglutinin II (SNA-II)-tetragonal crystal form- complexed to N-Acetylgalactosamine | |
4GVH | Q8ZQ06 | Crystal structure of Salmonella typhimurium family 3 glycoside hydrolase (NagZ) covalently bound to 5-fluoro-GlcNAc. | |
4HZM | Q8ZQ06 | Crystal structure of Salmonella typhimurium family 3 glycoside hydrolase (NagZ) bound to N-[(3S,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)piperidin-3-yl]butanamide | |
4GVF | Q8ZQ06 | Crystal structure of Salmonella typhimurium family 3 glycoside hydrolase (NagZ) bound to GlcNAc | |
7EZZ | P0A232 | Crystal structure of Salmonella typhi outer membrane phospholipase (OMPLA) dimer with bound calcium | |
6L3E | A0A0W3SG76 | Crystal structure of Salmonella enterica sugar-binding protein MalE | |
4WN3 | P13298 | Crystal structure of Saccharomyces cerevisiae OMP synthase in complex with PRP(NH)P | |
4WML | P13298 | Crystal structure of Saccharomyces cerevisiae OMP synthase in complex with PRP(CH2)P | |
2AJ4 | P04385 | Crystal structure of Saccharomyces cerevisiae Galactokinase in complex with galactose and Mg:AMPPNP | |
8X8K | O95210 | Crystal structure of STBD1 CBM20 domain in complex with maltotetraose | |
3WJ1 | Q5NU42 | Crystal structure of SSHESTI | |
6KX1 | 6KX1 | Crystal structure of SN-101 mAb in complex with MUC1 glycopeptide | |
7SPR | A8PUY1 | Crystal structure of SMG1 mutant (G28C/P206C/Q34P/A37P/M176V/G177A/M294R/F278N) | |
4ZRD | A8PUY1 | Crystal structure of SMG1 F278N mutant | |
4ZRE | A8PUY1 | Crystal structure of SMG1 F278D mutant | |
3WMP | A4CYJ6 | Crystal structure of SLL-2 | |
8FBW | 8FBW | Crystal structure of SIV-1 V2 antibody NCI05 in complex with a V2 peptide | |
8YXI | A0A2Z4HIM0 | Crystal structure of SFTSV Gn in complex with a neutralizing antibody 40C10 | |
8YXI | 8YXI | Crystal structure of SFTSV Gn in complex with a neutralizing antibody 40C10 | |
8WSP | F1BDJ0 | Crystal structure of SFTSV Gn and antibody SF5 | |
8WSP | 8WSP | Crystal structure of SFTSV Gn and antibody SF5 | |
8WSN | F1BWV6 | Crystal structure of SFTSV Gn and antibody SF1 | |
8WSN | 8WSN | Crystal structure of SFTSV Gn and antibody SF1 | |
2E50 | Q01105 | Crystal structure of SET/TAF-1beta/INHAT | |
6XQM | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with laminarihexaose, presenting a laminaribiose and a glucose at active site | |
6XQH | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with cellotriose, presenting a 1,3-beta-D-cellobiosyl-glucose and a cellobiose at active site | |
6XQL | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with cellohexaose, presenting a 1,3-beta-D-cellobiosyl-glucose at active site | |
6XQF | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with 1,3-beta-D-cellotriosyl-glucose, presenting a 1,3-beta-D-cellobiosyl-glucose at active site | |
6XQG | A0A0B5H9B3 | Crystal structure of SCLam E144S mutant, a non-specific endo-beta-1,3(4)-glucanase from family GH16, co-crystallized with 1,3-beta-D-cellobiosyl-cellobiose, presenting a 1,3-beta-D-cellobiosyl-glucose at active site | |
8H5U | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-021 | |
8H5U | 8H5U | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-021 | |
8H5T | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 | |
8H5T | 8H5T | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody Nb-015 | |
8SIT | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
8SIT | 8SIT | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
8SIS | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
8SIS | 8SIS | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
8SIR | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
8SIR | 8SIR | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
8SIQ | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
6M0J | Q9BYF1 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
6M0J | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
7X2H | 7X2H | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab | |
7X2H | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab | |
7WN2 | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab | |
7WN2 | 7WN2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab | |
7WNB | 7WNB | Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024